We only have this paper's title and publication details.
Read it at the sourceThe research finds that oral myelin oligodendrocyte glycoprotein reduces autoimmune disease symptoms in mice, suggesting a potential therapeutic avenue.
No takes yet. Share an insight, caveat, or question.
Haghmorad et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: